Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...
Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor ...
Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results